PT796618E - Tratamento e profilaxia da pancreatite - Google Patents

Tratamento e profilaxia da pancreatite

Info

Publication number
PT796618E
PT796618E PT97301773T PT97301773T PT796618E PT 796618 E PT796618 E PT 796618E PT 97301773 T PT97301773 T PT 97301773T PT 97301773 T PT97301773 T PT 97301773T PT 796618 E PT796618 E PT 796618E
Authority
PT
Portugal
Prior art keywords
prophylaxis
pancreatitis
treatment
pancreatitis treatment
troglitazone
Prior art date
Application number
PT97301773T
Other languages
English (en)
Inventor
Masaharu Fukami
Hiroyoshi Horikoshi
Toshihiko Fujiwara
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PT796618E publication Critical patent/PT796618E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Catching Or Destruction (AREA)
PT97301773T 1996-03-18 1997-03-17 Tratamento e profilaxia da pancreatite PT796618E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6106396 1996-03-18
JP25020196 1996-09-20

Publications (1)

Publication Number Publication Date
PT796618E true PT796618E (pt) 2002-06-28

Family

ID=26402115

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97301773T PT796618E (pt) 1996-03-18 1997-03-17 Tratamento e profilaxia da pancreatite

Country Status (19)

Country Link
US (1) US5753681A (pt)
EP (1) EP0796618B1 (pt)
KR (1) KR100542778B1 (pt)
CN (1) CN1178657C (pt)
AT (1) ATE212548T1 (pt)
AU (1) AU708315B2 (pt)
CA (1) CA2200126C (pt)
CZ (1) CZ283968B6 (pt)
DE (1) DE69710111T2 (pt)
DK (1) DK0796618T3 (pt)
ES (1) ES2167678T3 (pt)
HK (1) HK1003051A1 (pt)
HU (1) HUP9700598A3 (pt)
ID (1) ID16266A (pt)
IL (1) IL120443A (pt)
NO (1) NO313179B1 (pt)
NZ (1) NZ314406A (pt)
PT (1) PT796618E (pt)
TW (1) TW548102B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
NZ503794A (en) * 1997-10-08 2002-09-27 Sankyo Co Benzimidazole and imidazopyridine derived heterocyclic compounds, pharmaceutical compositions and uses thereof
ES2211053T3 (es) * 1998-03-30 2004-07-01 Japan Tobacco Inc. Procedimiento para producir un compuesto de isooxazolidindiona.
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1516617A2 (en) * 1998-07-21 2005-03-23 SmithKline Beecham plc Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
EP1196189A2 (en) * 1999-06-25 2002-04-17 Medtronic MiniMed, Inc. Multiple agent diabetes therapy
CN1155586C (zh) 1999-08-23 2004-06-30 杏林制药株式会社 取代的苄基噻唑烷-2,4-二酮衍生物
DE60020573T2 (de) 1999-08-23 2006-03-16 Kyorin Pharmaceutical Co., Ltd. Substituierte benzylthiazolidin-2,4-dion derivate
US6452014B1 (en) * 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) * 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
EP2413967A1 (en) 2009-04-01 2012-02-08 F. Hoffmann-La Roche AG Treatment of insulin-resistant disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
US5232925A (en) * 1987-09-04 1993-08-03 Beecham Group P.L.C. Compounds
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5194443A (en) * 1987-09-04 1993-03-16 Beecham Group P.L.C. Compounds
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
DK375789A (da) * 1988-08-18 1990-02-19 Syntex Inc Peptidderivater
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
AU7118694A (en) * 1993-07-13 1995-02-13 Janica M. Moizis Fastener for clothing
US5728720A (en) * 1993-12-27 1998-03-17 Japan Tobacco Inc. Isoxazolidinedione compounds and use thereof
IL113313A (en) * 1994-04-11 1999-09-22 Sankyo Co Heterocyclic compounds and pharmaceutical compositions containing the same
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
FR2721608B1 (fr) * 1994-06-22 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
US5703096A (en) * 1994-10-07 1997-12-30 Sankyo Company, Limited Oxime derivatives, their preparation and their therapeutic use
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem

Also Published As

Publication number Publication date
AU708315B2 (en) 1999-07-29
ATE212548T1 (de) 2002-02-15
DK0796618T3 (da) 2002-05-06
NO313179B1 (no) 2002-08-26
HU9700598D0 (en) 1997-05-28
EP0796618B1 (en) 2002-01-30
NO971219D0 (no) 1997-03-17
ES2167678T3 (es) 2002-05-16
CN1170575A (zh) 1998-01-21
AU1628597A (en) 1997-09-25
HUP9700598A3 (en) 1998-10-28
HUP9700598A2 (hu) 1998-09-28
CZ283968B6 (cs) 1998-07-15
CZ79097A3 (en) 1997-10-15
KR19980023975A (ko) 1998-07-06
NZ314406A (en) 2000-12-22
MX9702058A (es) 1998-03-31
HK1003051A1 (en) 1998-10-09
EP0796618A1 (en) 1997-09-24
DE69710111T2 (de) 2002-10-02
DE69710111D1 (de) 2002-03-14
IL120443A0 (en) 1997-07-13
CN1178657C (zh) 2004-12-08
IL120443A (en) 2000-07-16
NO971219L (no) 1997-09-19
ID16266A (id) 1997-09-18
CA2200126C (en) 2006-08-15
US5753681A (en) 1998-05-19
CA2200126A1 (en) 1997-09-18
TW548102B (en) 2003-08-21
KR100542778B1 (ko) 2006-04-14

Similar Documents

Publication Publication Date Title
PT796618E (pt) Tratamento e profilaxia da pancreatite
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
MA23603A1 (fr) Derives d'oxalylamino-benzafuranne et benzothienyle.
ATE504562T1 (de) 7-, 8- und 9-substitutierte tetracyclinverbindungen
TR200200068T2 (tr) Nematisital triflüorobütenler
ATE253063T1 (de) 5-ht1f-agonisten
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
AU6452194A (en) Pharmaceutical agents for treatment of emesis
ES2127396T3 (es) Inhibidores aromaticos de acetilcolinesterasa.
ID25478A (id) Agonis 5-ht1f
NO943765L (no) Aryloksybenzen-herbicidmidler
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
ATE339204T1 (de) Freisetzungsregulierende zubereitungen
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
NO905292L (no) Fremgangsmaate for behandling av slam som oppstaar ved elektroplettering av metaller.